肺癌亚型鉴别诊断；分子病理；肺癌耐药机制及生物标志物研究
Differential diagnosis of lung cancer subtypes; Molecular pathology; Biomarkers and drug resistance mechanism of lung cancer

中华医学会病理学分会病理大数据委员会 委员
Pathological Big Data Committee of Chinese Pathological Society
中华医学会结核病学分会病理专业委员会 委员
Pathological Committee of the Society of Tuberculosis, Chinese Medical Association
上海市医学会分子诊断委员会 委员
Molecular Diagnosis Committee of Shanghai Medical Association

从事胸部专科临床病理工作近10年，主要研究肺癌和胸腺瘤、分子病理和靶向治疗耐药机制。主持国家自然科学基金、上海市卫计委课题（面上项目）和新疆自然科学基金各一项。发表SCI专业学术论文20余篇，其中第一作者或并列作者10篇。入选上海市肺科医院青年人才库计划。

I have worked on thoracic pathology for nearly 10 years and focused on lung cancer and mediastinal thymic tumors. My interest in molecular pathology and targeted therapy resistance resulted in leading of National Natural Science Foundation of China, Shanghai Municipal Commission of Health and Family Planning (General program) and XinJiang Natural Science Foundation. I have published more than 20 SCI articles about lung cancer, 10 articles as the first author or co-author, and supported by Youth talents program of Shanghai pulmonary hospital.